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INTRODUCTION 
Data generated in this laboratory (1,2) utilizing a 
renal cortical slice preparation from sodium deficient rats, 
suggest that dopamine directly stimulates renin release via 
a beta-adrenoreceptor mechanism operating at the level of 
the juxtaglomerular cell membrane. This effect appears to 
be coupled with increases in the concentration of cyclic 
3' :5 1 -adenosine monophosphate (c-A}~) in the renal cortical 
tissue, suggesting the participation of this nucleotide as 
the intracellular mediator of the stimulatory effect of 
dopamine on renin secretion. Recently (3), we have further 
supported this concept by demonstrating that addition of the 
phosphodiesterase inhibitor, theophylline, to the kidney 
slice system, potentiates the renin release and c-~~ re-
sponses to exogenous dopamine administration. Additionally, 
tve have proposed (4) that dopamine may inhibit renin release 
through a dopamine-specific receptor as opposed to its beta-
adrenoreceptor mediated stimulatory effect, suggesting a 
dual regulatory role for dopamine in the overall regulation 
of renin release. 
, 
..i.. 
Intrarenal prostaglandins (PGs) have also been impli-
cated in-the control of renin release (5,6). la vivo (7,8, 
213,214) and in vitro (9,10) observations suggest that exog-
enous prostaglandin E2 (PGE2) stimulates renin secretion, 
2 
but in several instances (11-14) this agent was found to be 
ineffective in altering the release of renin. Alternatively, 
prostaglandin F2-alpha (PGF2-alpha) has been shown to either 
increase (10) or decrease renin release in vitro (9,13) or 
to have no effect in vivo (15). 
Renal synthesis of prostaglandins occurs mostly in the 
medullary areas (16,17), but some prostaglandins can also be 
~reduced in the renal cortex (18,19). Renal cortical prosta-
glandin synthesis has been shown to be stimulated by arachi-
onic acid (C20:4) administration (20,21), and to be inhibited 
by the effective prostaglandin synthetase blocker, indometha-
cin (22,23,215), as well as by other anti-inflammatory agents 
(24 ,25). Although the mechanism by tvhich intrarenal prosta-
glandins influence renin secretion may be related to their 
effects on the renal vasculature (26,27,216), recent in vivo 
data have suggested that they rnay affect renin release via a 
direct action on the juxtaglomerular cells (28). 
In vitro renal cortical preparations are particularly 
suitable for an effective evaluation of factors which may 
directly influence renin secretion. The release of renin 
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from the juxtaglomerular cells is influenced by a number of 
hemodynamic and humoral factors (29,30) and by the nervous 
system (31,32). An in vitro renal cortical system, by elimi-
nating these influences, thus allows for the examination of 
a direct action of prostaglandins and other agents on renin 
release. Furthermore, !g vivo (33,34) and in vitro (1,2,35,36, 
37) evidence suggests that dietary sodium deficiency not only 
increases resting renin release, but that it also potentiates 
the renin secretory rate elicited by sympathoadrenergic dis-
charge. Recent in vitro studies (38,39,40) have additionally 
demonstrated that dietary sodium deficiency also potentiates 
the resting concentration and release of intrarenal prosta-
glandins. Thus, a renal cortical slice preparation =rom sod-
ium deficient rats ~~hich maximizes renin release and possibly 
intrarenal prostaglandin concentration as ~vell, is a ·Jiable 
model for investigating the nechanism of action by which intra-
renal prostaglandins ma:;,r influence renin release. 
Therefore, in vie~v of the conflicting nature of the data 
regarding renal prostaglandin mediation of renin, this study 
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has been designed to (1) determine if exogenously administered 
prostaglandins of the E and F series can directly influence 
renin release in a renal cortical slice system from sodium 
deficient rats, (2) investigate if blockade of renal alpha-
and beta-adrenergic receptors modifies the renin secretory 
responses to prostaglandin administration, (3) examine if 
changes in renal cortical tissue c-A!~ content in response 
to prostaglandin treatment are coupled with those seen in 
renin release, and (4) evaluate if administration of indo-
methacin, an effective prostaglandin synthetase inhibitor, 
can influence the in~reased resting renin secretory levels 
seen in sodium deficient rats. A positive finding would sup-
?Ort the concept that intrarenal prostaglandins participate 
in the regulation of resting renin release in the sodium 
deficient state. 
LITERATURE REVIB~ 
I. Introduction to the Renin-Angiotensin System. (RAS) 
Since the discovery of renin by Tigerstedt (41) numer-
ous studies have clearly implicated the RAS in the regulation 
of blood pressure, primarily via the pressor action of Angio-
tensin II (ANG II) on peripheral blood vessels. The ANG II 
octapeptide is synthesized via the catalytic action of renin. 
In turn, renin cleaves angiotensinogen of hepatic origin to 
form the decapeptide Angiotensin I (ANG I), the immediate 
precursor of Angiotensin II. ANG I is in turn hydrolyzed by 
converting enzyme, present largely in the pulmonary vascular 
bed, to ANG II. Subsequent proteolytic action of circulating 
angiotensinases results in t~e formation of Angiotensin III 
(A~1G III), a peptide ~vith little pressor activity, and inac-
tive metabolites (30). The &~S has also ~een shown to func-
tion in the regulation of blood volume and electrolyte homeo-
stasis. ANG II has been demonstrated to influence sodium 
excretion throug~ its effect on the renal vasculature <vhich 
alters the filtered sodium load and the sum of Starling 
forces acting on the pertibular capillaries (42). Additional-
ly, ANG II infusions stimulate the synthesis and release of 
5 
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aldosterone and vasopressin (L~-3,44,217), which are of primary 
importance in renal sodium and ~Jater reabsorption. 
II. Anatomical Evidence. 
TI1e current accepted view places the site of formation, 
storage and release of renin in the juxtaglomerular cells 
(JG) of the afferent arteriole of the mammalian kidney, al-
though compounds with renin-like activity have been demon-
strated in extrarenal regions as well (45,46). Gra~ular cells 
lining the afferent arteriole wall closest to the glomerulus 
• 
were first reported by Cberling and Hatt (47) and later con-
firmed by other investigators (48,49,218,219,220), and sodium 
deficiency has been shown to increase the nQ~ber and granula-
tion of rat JG cells (53,37). 
III. Regulato~y Mechanisms Involved in the Control of Renin 
Secretion. 
A. The Hacula Densa Receptor. 
Substantial evidence suggests the existence of 
a functional relationship bet~veen the macula densa 
and the granular cells involved in renin secretion. 
Hovlever, the exact nature of the signal detected by 
the cells of the macula densa and the mechanism 1 DY 
~vhich the signal is detected and transmitted i:o the 
renin-secreting cells is still open to question. 
Barajas (43), based on electron micrographs of rat 
JG cells, has suggested that decreased contact be-
tween these cells and the macula densa cells of the 
distal tubule would result in increased renin secre-
tion. This decreased stretch of the tubular cells 
has been attributed to a lowered sodium load in the 
distal tubule with an accompanying volume reduction, 
thus resulting in decreased contact. 
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Hicro;_Juncture experiments (50) point to an in-
verse relationship between renin release and total 
sodium load delivered to the macula densa. This in-
verse relationship has been confirmed by Nash et al. 
(51) \vho demonstrated in dogs the dissociation of 
renin release from renal hemodynamics and water and 
sodium balance, but not from the filtered load of 
sodium. They suggested the existence of an intra-
renal, e:{travascular sodium-sensitive mechanism, 
which responds directly to changes in sodium flux 
across the macula densa. Recent '>1ork in the isolated 
rat ~ddney has lent support to this concept (52). 
Hm-vever, studies utilizing ret:::ograde injections of 
8 
high sodium buffer into the distal tubule have sug-
g~sted instead a direct relationship between fil-
tered sodium load and renin release (53,221). 
B. The R?nal Baroreceptor. 
Embryonically, JG cells are derived from stem 
cells ~vhich normally form smooth muscle (54), although 
they ~ave developed the ability to functionally behave 
as endocrine cells, which the remainin6 smootZ: muscle 
cells of t2e afferent arte~iole do not have. T2e 
2.2 tte:::, ~;.mvever, can indirectly affect JG cell func-
tion by responding to c~~~ges i~ the stretch of their 
~alls. T~erefore, t~e existe~ce cf a re~al vascular 
rece?tor, sensitive to stretch and thus to alterations 
in renal ?erfusion pressure has been investi~ated. 
In der:erva ted-, adrenalectomized-, :.on- fil terin6 ca-
nine ~ddneys, renin secretion has been observed to 
i~cr2ase in response to decre~sed renal ~erfusion 
pressure associated tvith hemorrl1a.r2:e and 5raded su?ra-
renal aortic constriction (55,56,57,222). This in-
creased renin secreto~y response was no longer appar-
ent "i.1en oerfusion pressures 'vere restored to normal 
1 ~ 
..L.eve.Ls. ?u:::therrnore, in vi-;o administration of the 
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smooth muscle relaxant papaverine has been demonstrated 
to abolish the renin secretory responses to hemorrhage 
in canine-denervated-, non-filtering kidneys (58), 
although it is possible that this effect may have been 
due to a direct effect of papaverine on the JG cells. 
Recent in vitro experiments utilizing a rat renal 
cortical cell suspension have shown papaverine may 
directly inhibit renin secretion (59). 
C. The Nervous System. 
1. Central Nervous System Regulation of Renin Release. 
The possibility of a brain renin-angiotensin 
system participating in the central re~ulation of 
perip'::eral blood pressure has long been debated. 
T.'lere is generalized agreement t'.1at circulating 
AFG II or ANG III influence some brain regions 
located outside t~e blood-brain barrier (60). 
Several components of t~1.e RAS 1.-:ave been demon-
strated intracerebrally as ~ell (51). }~wever, 
the issue of whether it is renin or an isorenin 
\-7l-:dch is 1?resent intracerebrally remains unreso 1 ved. 
Endo3enous brain renin and t~e renin-like enzyme, 
Cathepsin D, co-?urify by gel filtration and ammon-
ium sul;?bate fractionation (62); Cat~l.epsin D, as 
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does renin, will react :vith renin subs t:ra te to 
form ANG I (63), although the activity of this 
so-called "brain-renin11 decreases abo\re pH 7.0, 
Nhile the optimal pH for renal renin activity is 
at 7.4 (64). Recent investigations have demon-
strated a fraction of Cathepsin D which has renin-
like optional activity at pH 7.4 and is effective-
ly neutralized by anti-renin anti-sera (65,66,67, 
223,224,225). 
a. T~e Effect of Plasma Angiot~~sin on the Brain. 
Confirmation cf plasma angiotensin in-
fluence on the brain ~vas provided in an ele-
gant experiment by Bickert:on et al. (68). In 
this cross-perfusion study, the head of a 
recipient dog, isolated from its circulation 
but connected to its sninal cord, was perfused 
tvith blood from a donor dog receiving ANG II 
injected into its circulation. Peripheral 
arterial pressure tvas observed to increase in 
the recipient dog ;.vhile ANG II \vas infused 
into the donor. 
Nediation of plasma ANG II influence 
on the CNS must occur outside the blood-brain 
11 
barrier, since this pe~tide cannot cross the 
blood-brain barrier (69). The pressor re-
sponse to ANG II infusions into the vertebral 
artery of dogs has been shown to occur only 
if the circulation to the area postrema, out-
side the blood-brain barrier, remains unim-
paired (70). Moreover, injections of ANG II 
into the vertebral artery inhibit reflex vaso-
dilation in t~e dog (70), suggesting a possi-
ble role for ANG II in modifying the inhibi-
tory activity exerted bv vasomotor effector 
neurons (70). Neural connections have also 
been demonstrated between the area postrema 
and the nucleus of the tractus solitarius 
(70) which receives input from the gloss-
opharyngeal and carotoid sinus nerves and in 
turn operate as a relav for afferent baro-
receptor impulse integration (71). 
Direct administration of ANG II into 
the cerebral ventricles causes increased 
secretion of both vasooressin and ACTR and 
a rise in blood pressure (44,72). These 
12 
responses have been mimicked by intraventricu-
lar injection of purified renin (73), and 
responses to both peptides are abolished by 
the competitive ANG II antagonist, Saralsin 
(73). Additionally, converting enzyme inhib-
itors have been shown to block the response 
to intracerebral injection of renin (73), 
thus further supporting the view that the 
observed responses are due to ANG II of 
cerebral, rather than peripheral origin. 
b. Central Influence on Renal Renin Release. 
The postulation that the CNS plays a 
role in modulating renal renin release has 
been arrived at as a result of the following 
observations: (1) Cathepsin D, an enzvme 
a?parently containing a renin-lU\.e component, 
activates inactive renin in human amniotic 
fluid (74). This observation taken together 
~vith the intracerebral demonstration of 
Cathe?sin D suggests a possible central 
?hvsiological role for t~is enzyme; (2) cen-
tral mediation of peripheral activation of 
inactive renin has been s~own (75); (3) in 
13 
~ pharmacological evidence indicates that 
stimulation of central serotoninergic path-
ways increases peripheral renin release (76); 
(4) stimulation of the posterior hypothalamus, 
medulla oblongata, and pons, increases renin 
secretion and is associated with a rise in 
blood pressure; and (5) renal denervation 
abolishes the increase in renin release in 
response to central stimulation (73). 
Clonidine, a known central alpha-
receptor agonist agent, has several actions 
on the brain. It decreases plasma ACTI1 
through an action on the hypothalamus, and 
injections of this agent into the blood 
perfusing the medulla and the pons result 
in a significant depressor response (73). 
Furthermore, vertebral or carotoid arterial 
administration of clonidine produces a de-
crease in plasma renin activity (73). Bi-
lateral lesions of the canine ventral medul-
la abolish the decreased splanchnic nerve 
discharge associated with clonidine injec-
tion, while the depressor response remains 
• 
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intact. Thus, these data point to a separate 
site for the renin-lowering effect and the 
depressor responses to this agent (73). 
Injections of clonidine into the cis-
terna magna of anesthetized, bilaterally 
splanchnictomized dogs, do not result in de-
creased plasma renin activity, whereas the 
same dose injected into animals with intact 
splanchnic nerves result in a significant 
decrease in hemorrhage-stimulated increases 
in plasma renin activity. These data suggest 
that clonidine reduces sympathetically-
stimulated renin via a central mechanism de-
pendent on splanchnic nerve integrity (77). 
The renin-lowering effect of clonidine may be 
exerted through an excitatory action on intra-
cerebral alpha-adrenoreceptors (73). Clonidine 
has been shmvn to have a greater affinity for 
pre- rather than post-junctional alpha-
adrenoreceptors (78). Hor:Jever, the evidence 
regarding the action of clonidine on renin 
release is not yet complete. Clonidine ap-
?ears to decrease sympathetic discharge rate 
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even when pre-synaptic inhibition is abolished 
by reserpine-induced catecholamine depletion 
(79). Additionally, a neurally-mediated 
decrease in renin secretion, which can be 
abolished bv renal denervation, has also been 
reported when L-dopa is administered with car-
bidopa to provoke catecholamine release (80). 
Furthermore, while injections of norepineph-
rine, epinephrine and dopamine into the third 
ventricle of the dog increase renin secretion, 
injections of clonidine into the same site 
decrease renin secretion (73). ~1us, these 
data indicate that agents with high affini-
ties for post-synaptic receptors increase 
renin secretion while agents with high affini-
ties for pre-synaptic receptors decrease 
renin secretion. 
2. Peripheral Nervous System Regulation of Renin 
Release. 
a. Anatomical and Functional Evidence. 
A large body of evidence suggests that 
the sympathetic nervous system innervates the 
JG cells and thus can directly modulate renin 
16 
release. Electron microscopic studies (81-83) 
have clearly shown this extensive sympathetic 
innervation of the renin-secreting cells, and 
fluorescent histochemical studies and chemical 
assays (84,85) have further supported this 
view. Furthermore, circulating catecholamines 
of adrenal medullary origin can directly in-
fluence renin release by acting on renal 
adrenergic receptors, in addition to their 
indirect effects exerted through the renal 
baroreceptors and macula densa receptors 
(29-32). 
Functional evidence for a direct sympa-
thetic effect on renin secretion, independent 
of hemodynamic and macula densa influences, 
has been provided by numerous studies. In 
papaverine-treated dogs with non-filtering 
kidneys, electrical stimulation of the renal 
nerves increases renin release (86). Similar-
ly, in vitro administration of catecholamines 
stimulates renin secretion (1,2,35,36,87,88, 
96,98), presumably by a direct action on the 
JG cells. 
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b. The Renal Beta-AdrenerAic Receptor. 
Abundant in vivo and in vitro data have 
-- -
firmly established the concept that circulat-
ing catecholamines and norephinephrine re-
leased by renal nerve terminals, can direct-
ly stimulate renin release (1,2,89-93). This 
direct stimulatory effect appears to be exert-
ed via a JG cell membrane-bound beta-adreno-
receptor mechanism (36,90,94,96,100-102,104, 
226), since blockade of this receptor mechanism 
by specific pharmacological agents such as 
propranolol and pindolol effectively prevents 
the increase in renin release seen in response 
to sympathetic stimulation (31,36,90,92,9L:--97, 
100-104,227,228). 
Tiie stimulatory action of beta-adreno-
receptor activation on renin secretion has 
been suggested to be coupled ~·Jith a simultane-
ous increase in the levels of cyclic 3!5'-
adenosine m.onophosphate (c-Ar'IP) in renal tis-
sue (1,2,36) \v~1ich mav indicate that this 
nucleotide acts as the intracellular mediator 
of sympatl1etic stimulati.::>n of ::enin r2lease 
18 
(229). This vie~;·J has been further supported 
by the demonstration t~1at the phosphodiester-
ase inhibitor, t~eophylline, potentiates the 
stimulatory action of catecholamines en renin 
release (98,99,105,107). Additionally, admin-
istration of dibutyryl c-AHP to isolated rat 
renal cortical tissue increases renin release 
in a dose-dependent fashion (108), an observa-
tion tvhich has been confirmed in other in vivo 
and in ''i tro studies ( 90, 106, 109) . 
The type of beta-a~renoreceptor specif-
ically involved in the regulation of renin 
r2l·~ase has not yet been fully determined. 
~;_2cent data suggest t:l.e involvement of a beta1-
adrenoreceptor rat~er than a beta2-type similar 
to tte one present in cardiac tissue (110-112, 
230), but some in vitro studies indicate that 
the renal beta-adrenoreceptor may nc·t belong 
to either ty?e (113). Furthermore, Saruta et 
al. (114), have suggested that the decrease in 
renin release associated with beta-adrenergic 
blockade is due to a membrane stabilizi:::~ 
effect of the blocking agents rather than to 
their functional beta-blocking actions. 
c. The Renal Alpha-Adrenergic Rece2tor. 
19 
Stimulation of intrarenal alpha-adreno-
receptors has been shown to result in an 
inhibition of renin release (100,115-117). 
Furthermore, a1pha-adrenoreceptor antagonists 
have been demonstrated to abolish the inhibi-
t~ry effect of a1pha-adrenoreceptor activa-
tion of renin release (36,93,98,100,118). 
Taken together, these-observations suggest an 
inhibitory role for intrarenal alpha-adreno-
receptors in the regulation of renin release. 
d. The Renal Dooamine Receptor. 
Dopamine has been shown to be present 
in canine renal tissue (118). The renal vase-
dilating prooerties of this amine have been 
postulated to indirectly influence renin re-
lease (120,121,122), and t~ese renal vascular 
effects apparently involve .;m interaction t.Jith 
dopamine-specific receptors located on t~e 
renal vascular walls (123,124,125). 
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Dopamine has also been found to increase 
the c-N1P content of rat renal oarticulate 
preparations (126,127) which suggest that the 
renal vascular actions of this amine mav be 
mediated by adenvlate cvclase svstems func-
tionallv coupled with renal vascular dopa-
minergic receptors. Alternatively, the ob-
served changes i~ renal tissue c-AJ1P content 
in response to dopamine administration may re-
flect an action of this agent on cells other 
than vascular cells, such as the JG cells, 
suggesting adenylate cvclase mediation of a 
direct effect of dopamine on renin release 
(128,129). This possibilitv has now been 
suggested bv in vitro studies (1-3,130,131), 
in ~.vhich dopamine administration simultc:neous-
lv stimulated bot~ renin release and tissue 
c-AMP content in rat renal cortical tissue. 
Furt:1ermore, this effect ~vas shmvn to be 
effectively blocked bv propranolol in these 
studies, suggesting t~at mediation of the 
stimulatorv action of dooamine on renin 
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secretion is via a beta-adrenoreceptor mechanism. 
Converselv, administration of dopamine-receptor 
blockers such as haloperidol (f3l) and d-butaclamol 
(4) has been demonstrated to potentiate the stimu-
lation of renin release bv dopamine, tvhich may 
indicate that renal dopaminergic receptors may reg-
ulate renin release in an inhibitory fashion. The 
physiological significance of this dual regulation 
is unclear, but a similar dual type of control has 
• been proposed to exist in regard to the action of 
norepinephrine on renin release (36,115,117,118). 
3. Humoral Influences in the Control of Renin Release. 
a. Angiotensin II (ANG II). 
Peripheral infusions of ANG II have been 
shmvn to inhibit renin secretion (42). In sod-
ium deficient sheep (132), chronic ANG II ad-
ministration prevented the expected rise in 
plasma renin activity, seen in the sodium defi-
cient state. ANG II has also been reported to 
inhibit renin secre~ion in the absence of a 
functional renal baroreceptor or macula densa 
(133), suggesting a direct inhibitory action 
of ANG II on the JG cells. Furthermore, Keeton 
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et al. (134) have suAgested that infusions of 
saralasin, an ANG II competitive inhibitor, 
disrupts the ANG II short-loop, local inhibi-
tory feedback mechanism on renin release, 
which is also associated with the intrarenal 
beta-adrenoreceptors, and in vitro observa-
tions by Ganong and Lopez (36) have demonstrat-
ed that ANG II administration inhibits the 
stimulatory effect of norepinephrine on renin 
secretion, and that this effect is coupled 
with corresponding decreases in the c-AMP con-
tent of the renal cortical tissue. Thus, it 
appears that in addition to its indirect ac-
tions in the regulation of renin release, 
namely, via its central and peripheral vascu-
lar effects, ANG II has the abilitv to locally 
control the secretion on renin by a direct 
s~:ort-loop feedback mechanism operating at the 
JG cell level. However, a negative feedback 
effect exerted by ANG II on the JG cells was 
not observed in a recent in vivo investigation 
by Baer and her associates (135). 
b. Vasopressin (ADH). 
Some investigators have also reported 
that ANG II infusions increase the plasma 
concentration of vasopressin (44,136,137). 
Since it has also been shown that vasopres-
sin inhibits renin release (44,137,138), it 
may be possible that the inhibitory regula-
tion of renin release by vasopressin may be 
the result of ANG II-mediated central stimu-
lation of vasopressin release, although the 
actual mechanism by which vasopressin in-
fluences renin secretion remains unclear. 
c.. Electrolytes. 
23 
In addition to sodium, other electrolytes 
also appear to regulate renin secretion. Chlo-
rine has recently been reported to increase 
renin release in rats independent of sodium 
concentration (139). In experiments \•Jith de-
nervated, auto-transplanted canine kidneys, hy-
permagnesia has been demonstrated to stimu-
late renin release independent of hemodynamic, 
nervous and natriuretic factors (140). The 
mechanism of action involved in this effect 
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appears to be related to the antagonism which 
exists between magnesium and calcium in con-
trolling renin release. Recent in vitro work 
_...;..,;;...;;.,;;..;;. 
(141) has demonstrated that potassium-free 
media causes a depression of renin release in 
renal cortical tissue, and that this effect 
is partially prevented when calcium is also 
absent from the media. Vandongen and Peart 
(142) have also demonstrated that ANG II will 
not inhibit basal renin secretion in the 
absence of calcium. These observations point 
to a regulatory influence of calcium on a JG 
cell membrane response to ionic influences 
(231,232). 
4. Regulation of Renin Secretion by Intrarenal Prosta-
glandins. 
Synthesis of prostaglandins (PG) has been demon-
strated to occur in a variety of peripheral vascu-
lar beds (143,144). In the kidney, the concentra-
tion of PG synthetase is highest in the medulla 
and papillae but there is also significant PG 
production in the renal cortex (17-20,145-147). 
Renal cortical synthesis of prostaglandins is 
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dependent on the conversion of free arachidonic 
acid (C20:4) to the endoperoxide PGG2 via the 
action of cyclooxygenases. Subsequent reductase 
activity results in the biosynthesis of PGE2 or 
PGF2-alpha while isomerases catalyze the conver-
sion of PGG2 or PGF2 . Additionally, PGE2 may be 
converted to PFG2-alpha via the action of PGE 9-
ketoreductases (148). Although it is generally 
accepted that renal prostaglandins play a pre-
dominant role in the control of renal vascular 
dynamics (25,26,144), their presence in the renal 
cortex has led to numerous studies designed to 
investigate the possibility of a regulatory in-
fluence of these agents on renin secretion (5,6, 
149-155), either directlv or indirectly. 
a. Indirect Regulation of Renin Secretion by 
Prostaglandins. 
i. PG Involvement in the Macula Densa and 
Baroreceptor Control Hechanisms. 
Prostaglandins appear to be re-
quired for effective macula densa function. 
In unilaterally renal denervated-, contra-
laterally nephrectomized-, papaverine- and 
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propranolol-treated anesthetized dogs, the 
PG synthetase inhibitor indomethacin, has 
been shown to abolish aortic clamp-
stimulated increases in plasma renin ac-
tivity (156). Additionally, indomethacin 
can inhibit the increased plasma renin 
activity associated with decreased early 
distal tubular sodium load in both sodium-
replete and deficient rats (157). 
Studies utilizing adrenalectomized-, 
renal denervated-, propranolol-treated, 
non-filtering canine kidneys 111ith contra-
lateral nephrectomy, have suggested a role 
for cortical PGs in the intrarenal baro-
receptor control of renin release (158). 
In this study, indomethacin abolished the 
rise in plasma renin activity associated 
with decreased renal perfusion pressure 
and intrarenal infusion of C20:4. This 
suggests that cortical, rather than medul-
lary PGs are involved in t~.e intrarenal 
baroreceptor response, since medullary 
cyclooxy~enase products cannot be 
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transported to the cortex via t~bular 
fluid in treated anesthetized do;s, t~e 
PG synthetase inhi~itor indomethacin, has 
been shmvn to abolish aortic clamp-
stimulated increases in plasma renin 
activity (156). Additionally, indometha-
cin can inhibit the increased plasma 
renin activity associated with decreased 
early distal tubular sodium load in both 
sodium-replete and deficient rats (157). 
Studies utilizing adrenalectomized-, 
renal denervated-, pro?ranolol-t;:eated, 
non-filtering canine kidneys ~vith contra-
l2teral nephrectomy, have suggested a 
role for cortical PGs in the intrarenal 
baroreceptor control of renin release 
(158). In t~is study, indomethacin abol-
ished the rise in plasma renin activity 
associated ~vith decreased renal ryerfusion 
pressure and intrarenal infusion of C20:4. 
This suggests that cortical, rather than 
medullary PGs are involved in the intra-
renal baroreceptor response, since medullary 
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cyclooxvgenase products cannot be trans-
ported to the cortex via tubular fluid in 
the non-filtering kidney (158). These 
observations have been recently extended 
by the demonstration that PGE2 and PGI2 
of cortical origin are necessary for baro-
receptor stimulated renin release (159). 
Thus, current evidence suggests the in-
volvement of medullary and cortical PGs 
in t'tvo of the three major mechanisms which 
regulate renin release. 
ii. The Relationship Between PGs and Angio-
tensin II (ANG II). 
In vivo evidence has indicated endog-
enous renal PG mediation of the ANG II 
short-loop feedback mechanism. Adminis-
tration of tt..,e ANG I converting enzyme 
inhibitor, SQ 14225, results in a si~nifi­
cant increase in ?lasma renin activity 
~·1::-:.ich is abolished following indomethacin 
infusion (160). Indomet~1acin has also 
been shm·m to decrease ANG IT-induced 
aldosterone release in sodium deficient 
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rats (161). Alternatively, experiments in 
the isolated rat kidney suggest that ANG 
II increases PGE2 biosynthesis (162), and 
the production of an increased renal venous 
PGE-like agent associated tvith lortJ frequency 
renal nerve stimulation, has also been re-
ported to be mediated by ANG II (163). 
iii. PGs and the Renal Nerves. 
vrr~ile experimental evidence suggests 
a role for PGs in modulating sympathetical-
ly-evoked renin release, the mechanism 
involved in this action has not yet been 
determined (164,165). In renal-denervated 
dogs, treated with cvclooxygenase inhibi-
tors while undergoing hemorrhage, plasma 
renin activity remained unaltered in rela-
tion to control levels (166). However, 
direct stimulation of the renal sympathetic 
nerves in anesthetized dogs has been sho~·m 
to simultaneously increase renin release 
and PGE2 levels t\vo-£old over those of 
control (167). Furt~ermore, isoproternol-
stimulated renin release in rats is reduced 
by 67% following administration of J 
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indomethacin, while this same agent attenu-
ated the rise in serum renin levels caused 
by the beta1-adrenoreceptor agonist Hl33/22 
by 80% (168). Catecholamine infusions have 
also been reported to increase PG release 
in the isolated, perfused rabbit kidney, 
thus suggesting a role for the renal 
nerves in stimulating PG synthesis (169). 
These observa.tions taken together, support 
the existence of a mechanism whereby sympa-
thetic stimulation, which may be under the 
tonic restraint of cardiovascular reflexes, 
evokes simultaneous increases in renin re-
lease and PG biosynthesis, with PGs act-
ing at a site distal to ths intrarenal 
beta-adrenergic receptor. 
iv. PG Synthetase Inhibitors and Their Relation 
to the RAS. 
In an attempt to clarify the mechanism 
bv '.vhich intrarenal PGs may influence renin 
release, the non-selective, cyclooxy~enase 
inhibitor, indomethacin, has been utilized 
in a number of investigations. Indomethacin, 
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in doses of 5-10 mg/kg, has been reported 
to significantly decrease resting (basal) 
plasma renin activity in rabbits and dogs 
(19,20,233). Similar doses have also been 
reported to lower the level of immunoreac-
tive renal venous PGE substances, as well 
as to decrease plasma renin activity in 
normal and hypertensive rabbits (22,24,25, 
170). Studies in normal and hypertensive 
man have generally supported these obser-
vation~ (171-173,234). 
Indomethacin can also suppress the 
rise in the levels of active renin asso-
ciated with furosemide administration 
(174) and to decrease those of inactive 
renin and acid-activated renin in man, 
which suggests that PGs may mediate the 
conversion of inactive to active renin 
(175). Additionally, recent in vivo stud-
ies ~1ave confirmed t~1ese observations and 
have further suggested a definite role 
for newly synt~esized PGs in regulating 
r2nin release via a direct action on the 
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JG cells (19,20,177,178). 
Recent 1a Y!Y£ investigations util-
lizing non-filtering-, denervated-, papa-
verine-treated canine kidneys, support the 
concept of a direct action by PGs on the 
JG cells to mediate renin release (28). 
In these studies, 60-min infusions of 
C20: 4 (15 ug/l~g/min) produced significant 
increases in both renin release and PG 
levels. On the basis of these results 
it appears likely that the C20:4- evoked 
increases in renin release are due to a 
prior conversion of C20:4 to prosta-
glandins which then influence the JG 
cells, independent of other regulatorv 
mechanisms. 
ii. Effect of PGE2 . 
In vivo and in vitro evidence sug-
gest that PGE2 either increases or does 
not alter renin release under a variety 
of experimental manipulations. Utilizing 
a rabbit renal cortical cell preparation, 
-12 
PGE2 at various concer-.trations (3xl0 H, 
1 ~,,i 
\ ". ,, 
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-, 0 -7 3xl0 ... M, 3xl0 H) has been shown to in-
crease renin release ':vith maximal stimula-
tion produced by the lo~-Jest concentration 
of PGE2 used (9). In another study (10), 
a dose of 2.0 ug/ml of PGE2 caused a grad-
ual increase in renin release over sixty 
minutes of incubation, and PGE2 doses from 
-6 -4 3xl0 M to 3x10 M have recently been 
shmvn to increase in vitro renin release 
in a dose~dependent manner in rats (179). 
Furthermore, in isolated rat glomeruli, 
administration of 5 ug/ml of C20:4 pro-
duced a tenfold increase in PGEz and a 
twofold increase in renin release (180). 
In the isolated, perfused rat kidney, 
thirty minute infusions of 5, 10 or 50 
ng/ml of PGE2 have been reported to pro-
duce significant dose-dependent increases 
in renin release (181). Similarly, in the 
anesthetized dog, 10-min. infusions of 
14-60 ng/kg/min of PGE2 resulted in dose-
dependent increases in both renin release 
and renal blood flmv ( 7), \A7hile 
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administration of acetylcholine, bradykinin, 
and the depressor agent eledoisin only in-
creased renal blood flmv without affecting 
renin release, thus suggesting a direct 
action of PGE2 on the JG cells to influence 
renin release (7). Yun and his associates 
have also reported increases in renin re-
lease in sodium deficient dogs with non-
filtering kidneys, follmving 60-min infu-
sions of PGE2 (4.12 ug/min and 1.03 ug/min), 
fur~her supporting the concept of a direct 
role for PGs in modulating renin release 
(15,182). Additionally, chronic intra-
renal infusion of 2 ug/min of PGE2 over 
7-8 days in unilaterally-nephrectomized, 
conscious dogs, resulted in eight-fold 
increases in plasma renin activity tvhich ~:.vas 
attenuated following SQ 14225 administration 
on day 9 (183,184). Thus, taken to;sether, 
these data support the view of a direct ac-
tion of PGE2 on the renin-secreting cells 
to influence renin release, although the 
mechanism involved in this action remains 
unclear. 
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-6 In contrast, 10 M PGE2 has been 
reported to be ineffective i~ altering 
renin release in rabbit renal cortical 
slice preparations (13,14,185). Similar-
ly, intrarenal infusions of PGE2 (0.1-5.0 
ug/min) for sixty minutes in renal-
denervated, anesthetized dogs have also 
failed to elicit significant increases 
in plasma renin activity (11), and 30 min 
infusions of 10-5000 ng/min of PGE2 have 
also been reported to have no effect on 
plasma renin activity in anesthetized dogs 
(12). Therefore, at present the possibil-
ity of a stimulating influence of this 
prostaglandin on renin secretion requires 
further evaluation, in view of the con-
flicting nature of the data currently 
available. 
iii. Effect of PGF~-alpha. 
Data pertaining to a possible in-
fluence of PGF2-alpha on renin secretion 
are also conflicting. 1£ vitro studies 
using rabbit renal cortical cell prepara-
tions (9), have shown that PGF2-alpha at 
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-12 -9 
various doses (3xl0 H, 3xl0 M and 
-7 3xl0 M) significantly decreases renin 
release. Furthermore, the addition of 
-12 -6 10 H to 10 ~1 of PGF 2 -alpha to rabbit 
renal cortical preparations have also re-
sulted in significant decreases in renin 
release in a dose-dependent fashion (13, 
14). Conversely, recent studies (10), 
utilizing similar renal cortical systems 
have demonstrated that 0.2 ug/ml PGF2-
alpha stimulates renin release when the 
prostaglandin was prepared in albumin-
containing physiological buffer, while 
the same dose inhibits basal renin re-
lease ~vhen the vehi_cle tvas ethanol (10). 
Alternatively, unilateral, intrarenal 
infusions of 1.03 ug/min of PGF2-alpha 
for 1.5 hours had no demonstrable effect 
on renin release in intact canine kidneys 
(15). 
iv. Effect of PG Endoperoxides. 
Current evidence indicates that the 
PG-synthetase intermediates, the 
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endoperoxides, are capable of stimulating 
renin release in vivo and in vitro. For 
instance, in vivo unilateral infusion of 
a synthetic PG-endoperoxide analogue, EPA, 
significantly increases renin release and 
this effect is prevented by prior treat-
ment with indomethacine (186), although 
the rise in renin release in response to 
EPA administration appears to be the re-
sult of prior conversion of EPA to PGE2 
(186). In vitro studies (13,14) utiliz-
ing a rabbit renal cortical preparation 
have also shown that the synthetic endo-
peroxide analogues EPA I and EPA II and 
the naturally occurring endoperoxide, 
PGG
2
, can significantly stimulate renin 
release to a similar extent (60% over con-
trol levels). Since in these studies PGE 
2 
was without effect and PGF2-alpha actually 
decreased renin secretion, it appears that 
the PG endoperoxides themselves are respon-
sible for the observed rise in renin 
secretion. 
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v. PG-elicited Stimulation of Cyclic AMP. 
It is generally accepted that intra-
renal PGs stimulate renal tissue cyclic 
A11P levels, but whether this is a non-
selective effect of PGs on intrarenal 
adenylate cyclase systems or a specific 
action on JG cell membrane adenylate cy-
clase complexes, is not clear. In iso-
lated rat glomeruli, adenylate cyclase 
stimulation, has been shown to occur fol-
-5 lowing administration of 2xl0 M PGE2 , 
while equimolar concentrations of PGF2-
alpha were ineffective (187). Also, high-
er concentrations of PGE2 and PGF2-alpha 
-4 (8xl0 M) have resulted in a significant 
stimulation of cyclic AI>1P content of rat 
renal cortical slice tissue (188). Con-
versely, a 10-fold decrease in the concen-
tration of PGF2-alpha resulted in the loss 
of the stimulatory action of this agent on 
renal cortical cyclic A~P content. Simi-
lar results have been reported in experi-
ments utilizing both renal medullary and 
cortical slice tissue (189,190). Unfor-
tunately, renin release changes were not 
simultaneously evaluated in any of these 
studies. Recently, unilateral, intra-
renal infusion of dibutyryl cyclic AMP 
into the renal artery of anesthetized 
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dogs, has been shown to significantly 
stimulate renin secretion even in the 
presence of indomethacin, suggesting that 
PG-synthetase activity does not play a 
role in cyclic A}W-mediated renin release 
(191). Indomethacin has also been re-
ported to be ineffective in altering theo-
phylline-induced increases in plasma renin 
activity in rabbits (192), while theophyl-
line has been shown to directly stimulate 
PG-synthetase in rabbit renal microsomes 
(193). Taken together, these results sug-
gest that the stimulatory effect of PGs on 
renal adenylate cyclase systems may be con-
fined to vascular and tubular cells differ-
ent from the JG cells. 
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vi. PGs and Their Relationship to the JG Cell 
Beta-adrenergic Receptor. 
Independent observations that intra-
renal PGs are capable of stimulating renin 
release as well as renal tissue cyclic Al~ 
content, pose the attractive possibility 
that the effect of PGs on renin secretion 
may be mediated by a membrane receptor 
mechanism which utilizes cyclic AMP as the 
intracellular second messenger, similar to 
the beta-adrenergic receptor mechanism 
which modulates the stimulatory effect of 
catecholamines on renin release via media-
tion by cyclic A}W content changes (1-4,35, 
36). This possibility is supported by in 
vivo 
.............. 
studies (194-196,235), showing that 
indomethacin administration can suppress 
the anti-hypertensive effect of beta-
adrenoreceptor blockade in man, cats and 
rabbits. However, in isolated rat glomer-
uli (197), beta-adrenoreceptor blockade 
has failed to inhibit the increased re-
lease of renin seen in response to C20:4 
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infusions, thus suggesting that PGs stimu-
late renin release independently of a beta-
adrenoreceptor mechanism. Furthermore, !a 
vivo studies have demonstrated the failure 
............ 
of indomethacin to prevent the rise in 
plasma renin activity produced by norepi-
nephrine and isoproterenol infusions in 
the dog (198). Recent studies utilizing 
superfused rat renal cortical slices (179), 
have shown that PGE2-induced renin release 
cannot be blocked by doses of propranolol 
which normally abolish isoproternol-
stimulated renin release. Thus, the bulk 
of the evidence suggests that while cyclic 
AMP may perhaps mediate PG-elicited renin 
release, the mechanism involved in this 
action may not be of the beta-adrenorecept-
or type and that the systems may function 
independently of each other in regulating 
renin secretion. 
MATERIALS AND METHODS 
Twelve male, Sprague-Dawley rats (Sprague•Dawley Co.) 
were fed a sodium deficient diet (Teklad Test Diet Co.) pro-
viding less than 0.02 mEq. of sodium per day for 2.5 to 3.5 
weeks and had free access to distilled, deionized water. The 
rats were kept in a temperature- and light-controlled room 
0 (23+2 C; 12 hours light and 12 hours dark), Nith two animals 
-
per cage. At the end of their dietary intake period the 
animals were sacrified by decapitation, their kidneys placed 
in Robinson's buffer medium at 4°c (199), and subsequently 
gassed for 30 sec. with a mixture of 95% o2-5% co 2 prior to 
and after decapsulation. Slices of renal cortex (approximate-
ly 0.3 mm thick) were prepared using a Stadie-Riggs microtome 
(A. Thomas Co.). Each cortical slice was further divided in-
to several similarly-sized portions (according to the number 
of treatments) and then randomly assigned to separate incuba-
0 
tion vessels containing 2.5 ml of ~obinson's buffer at 4 C. 
This procedure Nas repeated using slices from other cortical 
areas until each vessel contained 50~30 mg of cortical tissue 
(wet weight). The random distri~ution of the sliced tissue 
insured t:hat all i.ncuba tion beakers contained relati~rely 
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homogenous cell populations from each cortical area. One ves-
sel froai each group Nas utilized as a common, non-treated con-
trol. The renal cortical tissue ~vas then preincubated for 15 
min at 37°C in a shaking Dubnoff ~1etabolic Incubator (Pre-
cision Scientific Co.) in an atmosphere saturated with 95% 
02 - 5% co2 • The preincubated slices were subsequently trans· 
ferred to new incubation vessels containing 2.5 m1 of fresh 
Robinson's buffer and incubated for 60 min under 95% o2 - 5% 
0 co 2 at 37 C. 
• 
Groups of beakers having a common, unstimulated control 
-5 
sample, were treated with either prostaglandin E2 (PGE2 ; 10 M) 
or prostaglandin F,-alpha (PGF2-alpha; 10-
5M) added se?arate-
lt -
ly or together with the beta-adrenergic receptor blocker pro-
' 
-...;. 
pranolol (10 M), or the al?ha-adrenergic receptor blocker 
-I.!. phentolamine (10 ~·1) to the renal cortical slice preparation. 
-4 T.~e prostaglandin synthetase inhibitor, indomethacin (10 M), 
as ~vell as orooranolol and ohentolarnine tvere also added alone 
. . . 
tc the kidney slice system. 
~~domethacin, PGE2 and PGF2-alpha solutions were pre-
pared in absolute ethanol to t~e d~~ired concentrations. Pro-
pranolol (Sigma) r.vas dissolves in 0.1% ascorbic acid, \vhereas 
phentolamine (CIBA) solutions ~vere made in sterile r.vater. The 
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alpha- and beta-receptor blocking agents as well as indometha-
cin were added to the tissue preparation before ~oth the pre-
incubation and incubation periods. In turn, the prostaglan-
dins were added before the 60 min incubation period only. 
Following incubation, the supernatant medium ~-~as col-
o lec~ed and stored at -20 C before ~eing measured for renin 
concentration by radioimmunoassay of angiotensin I (200). 
The incubated tissue used for cyclic AHP content determina-
tion was immediately frozen on dry ice, homogenized in 8% 
tr~chloracetic acid, and stored at -20°C, until assayed by 
a rnodificc:.tion of the com-petit:i,,e protein-binding assay of 
Gilman (201). 
Ex-:raction and measurement of tissue cyclic Atv.!P 'i7ere 
accomplished by thatving the ?reviously frozen tissue hcmo-
3enatas in an ice-cold water bath folletved by centrifugation 
0 
at 4000 rpm for 15 min at 4 C. Tl"le supernatant 'vas t'.1en 
t-:::-2-nsferred to conical centrifuge tubes while the precipitat-
.;;d. ?rote in ~vas discarded. The samples were subsequently 
'·iashed four ti:nes ~vith 2.0 ml each of \vater-saturated ether, 
and the ether chase discarded. After the final wash, the 
c:;clic Al·.!P-containing Nater :J::ase r.vas decanted into glass 
6laced on dry ice for ra~ii ,. . :creez~n5. The frozen 
samples ~·1ere t!.l.en lyophyilized and the freeze-dried residue 
was stored at -20°C prior to the measurement of cyclic ~~~ 
content. ~e values were expressed as picomoles of cyclic-
Al1P per mg of wet tissue. 
Renin concentration in the supernatant samples was 
indirectly measured by determining the rate of angiotensin I 
generation following exposure of endogenous renin present in 
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the collected medium, to exogenous renin substrate (angioten-
sinogen) obtained from 6 hr nepnrectomized dog plasma, during 
0 
a t:vo-hour incubation period at 37 C. Angiotensinase-and 
converting enzyme inhibitors \-7ere added to the mixture t:o pre-
'lent conversion of the generated angiotensin I to angiotensin 
-.. l.l.. 
,,oc 
'+ ' 
Briefly, the supernatant samples were allowed to thaw at 
vortexed for 10 sec and 0. 025 ml aliquo ts ~vere trans-
ferred to test tubes at 4°C. Aliquots of 0.4 ml nephrecto-
rnized dog plasma (?H=7.56), previously treated with the 
angiotensinase-and converting enz~e inhibitor ?henyl methyl 
sulfonyl fluo::ide (PHSF:Sigma) and 2 drops of saturated NaCl, 
\vere then added to.each test tube and vortexed. T~e resulting 
mixture ~vas incubated for 2 hr at 37°C, diluted 3:1 ~vith acidi-
fied distilled water, vortexed, and then placed in a boiling 
\vater bath fer 3 min to terminate the reaction. The samples 
were then allo~ed to cool and then stored at -20°C until as-
sayed for angiotensin I by radioimmunoassay. The results 
were expressed as nanograms of angiotensin I per mg of wet 
tissue ?er hr. 
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Statistical analysis of the data was performed by modi-
fied Student's paired t-tests (202) using a programmable desk 
top calculator (Hewlett-Packard) at Argonne National Labora-
tories (Argonne, Il.). 
RESULTS 
-5 -5 The effect of ?GE2 (10 M) and PGF2-alpha (10 M) on 
renin release and cyclic AMP content in renal cortical slices 
from sodium deficient rats, is shot.;~n in figure 1. At the dose 
used, both prostaglandins increased renin secretion by about 2 
ng/mg/hr (in 5 out of 9 observations for PGE and in 6 out of 
2 
10 cases for PGF2-alpha) during a one-hr incubation period, 
although the increase was not statistically significant. In 
contrast, tissue cyclic AMP in res?onse to administration of 
either PGE2 or PGF2·alpha l:-7as markedly elevated (p 0.01). in 
relation to unstimulated, control samples (significant in-
creases in 11 out of 12 instances for PGE2 and in 10 out of 
12 cases for PGF1 -al?ha) . 
.... 
Administration of the beta·adrenorecentor b1oc~~er, ~'!"o-
not 
.~ 1 t- -:. .,... ..,.. o .... ~ n .,.. .-==- 1 :. as c. ( 1 ., ,;. - . .. ~ 1 0 ~ '"' ,_ :::> ,., ,.. ·~ 
-·- --·- ............... - __ ._ .... , ___ ·' - .t- 0- -~ ...... s ~-------S 
~~3 increased by PG:" ?lus 
~ 
.,ro ,.,.,..a '"'O 1 o l · 
.. ;::-- .... - -' i::1. 11 out of 12·c~ses 
tissue c-.\.:iF ~van increased plus proprar:.olol) 
.::ct "Jrevent t::e sti.::1ulato::·r ~ffect of PGZ,.. alone on t:~e cyclic 
\-~ 
- t.. , • ',:;'. ? ' content ct t .. e ::e'1a.l. t~ssue ~- :o.:;ure - 1 • 3imilar res•.1lts 
4i 
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(in 5 out of 10 cases renin release was increased by PGE2 plus 
phentolaMine; in 11 out of 12 cases tissue CA}~ content by PGEz 
plus phentolamine) were obtained when the alpha-adrenoreceptor 
-I. 
blocker, phentolamine (10 'M), :11as added to the renal cortical 
?reparation eit~er alone or in conjunction with PGE? (Figure 3). 
-
Changes in renin release and tissue cj·clic A}·fP content in 
response to administration of 10-5~ PGF2-alpha, either alone or 
-4 -4 
together ~vith 10 H propranolol or 10 M phentolamine, are 
shown in figures 4 and 5, respectively. As seen previously 
• 
~·;it:!:l PGE2 , beta- or al;>ha-adrenergic receptor blockade ~-Jas 
i~effective in altering renin secretion (renin release ~as 
i~creased in 6 out of 10 cases by PGF2-alpha plus propranolol 
and in 6 out of 10 cases of PGF2-alpha plus phentolamine) or 
in preventing the significant stimulatory effect of ?GF~-alpha 
"-
on tissue cyclic ~~~ content. (Tissue c-~-~ content was in-
creased in 11 out of 12 cases by bot~ PGF2-alpha plus propran-
olol and PGF2-alpha ?lus phentolamine.) 
To evaluate the possibility t~at endogenous prostaglan-
dins participate in the regulation of resting (basal) renin 
r:lease, the prostaglandin synthetase inhibitor, indomet~acin 
-4 (10 :-:) ' dd d 1 h 1 • • 1' ..J • was a e a~one to t e ~~dney s ~ce system ~ur~ng a 
cne-hr incubation ?eriod (Figure 5). In the presence of t~is 
agent, both renin release and tissue cyclic .~~ content re-
mained unaltered ~-Jhen compared to unstimulated control sam-
ples. (Renin release was increased in 1 out of 5 instances 
and c-A}~ content inc=eased in 2 out of 6 cases in response 
to indomet~acin.) 
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Figure 1. -s -s !£feet of 10 M prostaglandin E2 (PGE2) and 10 
prostaglandin F2-alpha (PGF2-alpha) added separately, on 
renin release and tissue cyclic ~~~ content in renal corti-
cal slices from sodium deficient rats. The data represent 
the mean renin release change ± SE and the mean tissue cyclic 
A}~ content change ± SE. TI1e number of observations (n) and 
the statistical significance of the observations are indi-
cated. The mean control (nontreated) rate of renin release 
was 6.39 ± 1.29 ng/mg/hr and the mean control tissue cyclic 
A: IF content Nas 0. 34 + 0. 04 pmol/mg •.vet tissue. Incubation 
time \vas 60 min. 
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Figure 2. Changes in renin release and tissue cyclic M·~ con-
-" tent in response to 10 ~ M prostaglandin E2 (PGE2) added alone 
-4 
or together r,.;ith 10 ~1 propranolol (PRO) to renal cortical 
slices from sodium deficient rats. The data represent the 
mean change in renin release ± SE and the mean tissue cyclic 
~~ content change ± SE. The number (n) of observations and 
the statistical significance of the observations are indi-
cated. The mean control (nontreated) rate of renin release 
for PGE2 added alone or together with ~0 was 6.30 ± 1.29 
ng/m.g/hr and it: Nas 6.42 + 1.65 ng/mg/hr for PRO added alone. 
Corresponding values for tissue cyclic rll'I? content ~-1ere 0. 34 
± 0.04 and 0.39 ± 0.08 pmol/mg ~vet tissue, respectively. 
Incubation time \vas 60 min. 
52 
7.0. 
6.0 Ill 
CHANGE IN 5.0. ~ 
RENIN RELEASE 
<nglmg/hr) 
4.01. 
3.01. 
2.o •• 
1.0. I" 
0 
0c"ange In Renin Release 
mil Change In cAMP 
n:9 n:12 
POE (10-S,) 
2 
MM slgneflcantly different from control tP < .00 
--
n:::ro n=12 
PGE2<10-~) 
PROPrfANOlOl 
cto-4Ml 
TREATMENT 
-r--
n:S n=6 
PROPRANOlOl 
(10-4M) 
1" 2.1 
• ~ 1.8 
• " 1.5 
• ~ 1.2 
• "0.9 
·~ 0.6 
• ~ 0.3 
CHANGE IN 
cAMP 
(Pmol/mg) 
CONTROl 
Figure 3. Changes in renin release and tissue cyclic ~~ 
-5 
content in response to 10 M prostaglandin E2 (PGE2) added 
-<+ 
alone or together with 10 ~ phentolamine (PHEN) to renal 
cortical slices from sodium deficient rats. The data repre-
sent the mean change in renin release + SE and the mean tis-
sue cyclic &~ content change ± SE. The number (n) of obser-
'lations and the statistical significance of the observations 
are indicated. ~1e mean control (nontreated) rate of renin 
relea.se for PGE2 added alone or together with PEEN ~Nas 6. 30 
± 1.29 ng/mg/hr and· it Nas 6.42 ± 1.65 ng/mg/hr for PHEN 
added alone. Corresponding values for tissue cyclic Ai'~ con-
tent ~~Jere 0.34 + 0.04 and 0.39 .:t 0.08 pmol/mg wet tissue, 
respectively. Incubation time was 60 min. 
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Fi.::aure 4. Changes in renin release and tissue cyclic AMP 
-5 
content in response to 10 !·f prostaglandin F 2-alpha (PGF 2-
-4 
alpha) added alone or together ~vith 10 M propranolol (PRO) 
to renal cortical slices from sodium deficient rats. The 
data represent the mean change in renin release + SE and 
the mean tissue cyclic &~ content change ± SE. The num-
ber (n) of observations and the statistical significance 
of the observations are indicated. The mean control (non-
treated) rate of renin release for PGF2-alpha ~dded alone 
or together with PRO was 6.30 ± 1.29 ng/mg/hr and it was 
6.42 + 1.65 ng/mg/~r for PRO added alone. Corresponding 
values for tissue cyclic AMP content were 0.34 + 0.04 and 
0.39 ~ 0.08 pmol/mg wet tissue, respectively. Incubation 
time t;-7as 60 min. 
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Figure 5. Changes in renin release and tissue cyclic Al1P con-
-5 
tent in response to 10 M prostaglandin F
2
-alpha (PGF2-alpha) 
-4 
added alone or together with 10 M phentolamine (PHEN) to 
renal cortical slices from sodium deficient rats. The data 
represent the mean change in renin release + SE and the mean 
tissue cyclic A}~ content change ± SE. The number (n) of ob-
servations and the statistical significance of the observa-
tions are indicated. The mean control (nontreated) rate of 
renin release for PGF2-alpha added alone or together with 
PHEN was 6.30 + 1.29 ng/mg/hr and 6.42 ± 1.65 ng/mg/hr for 
PHEN added alone. Corresponding values for tissue cyclic 
A~~ content were 0.34 + 0.04- and 0.39 + 0.08 pmol/mg wet 
tissue, respectively. Incubation time was 60 min. 
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Figure 6. The effect of 10-4M indomethacin (I) on resting 
renin release and tissue cyclic A}W content in renal corti-
cal slices from sodium deficient rats. The data represent 
the mean renin release + SE and the mean tissue cyclic AMP 
content + SE of I-treated slice tissue (I) in relation to 
unstimulated controls (c). The number (n) of observations 
are indicated. Incubation time was 60 min. 
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DISCUSSION 
The in vitro renal cortical slice preparation has been 
demonstrated to be a metabolically-viable system, as judged 
by the linearity of renin release and tissue oxygen consump-
tion observed with time of incubation (1,3,203-207). Utili-
zation of this type of preparation, which is devoid of hemo-
dynamic, humoral and other factors knotvn to affect renin 
secretion in the live animal, has allowed an effective eval-
• 
uation of the direct effect of a number of isolated agents 
on renin releas.~ (1-4,87 ,96,98,101,117 ,208-211), including 
those exerted by prostaglandins (9,10,13,14). 
In the present study, the inability of both PGE2 and 
?GF
2
-alpha to significantly stimulate renin release in vitro 
is consistent with previous reports whic~ suggest that admin-
istration of these agents either does not affect renin re-
lease (11,12,15) or it only exerts a mild stimulatory effect 
(10). Alternatively, some studies (7,179,181,182) have pro-
vided data supporting the concept that PGE., ~1as the ability 
.::. 
to significantly stimulate renin release, whereas oth~~rs 
(9,13,14) have reported that PGF"-alpha significantly de-
" 
?resses renin secretion. 
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One possible explanation for the ccnflicting nature of 
the data generated in these various studies, may be related 
to the nature of the vehicle in which the prostaglandins are 
routinely prepared. wnorton et al. (10) have shown that 
'Nhen ethanol is used as the solvent, concentrations of this 
agent as low as ul/5 ml of incubation medium diminish the 
stiw1latory effect of PGE1 on renin release by 33%, and 
that administration of similarly-prepared PGF2-alpha actual-
ly inhibits renin secretion. Conversely, the same investi-
gators have shown that PGF2-alpha significantly stimulates 
renin release only when dissolved in albumin-containing 
physiological buffer. Although there are no corresponding 
data pertaining to PGE , the fact that absolute ethanol was 
2 
utilized in the present study as the prostaglandin vehicle, 
may partially account for the inability of both PGE2 and 
PGF2-alpha to significantly influence renin release. A 
likely tvay by rl'1hich ethanol may participate in the preven-
tion of the stimulatory effect of these prostaglandins on 
renin secretion may be through its tvell-knmvn dehydrating 
properties, tvhich tvould impair the metabolic viability of 
the renal cortical cells. Hmvever, our observation that 
the cyclic AHP content of our renal cortical tissue tvas sig-
nificantly increased, rather than decreased, by the addition 
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of PGE
2 
and PGF2-alpha in this study makes a detrimental effect 
of ethanol a less likely possibility. 
To our knowledge, renin release and tissue cyclic A.~ 
content responses to prostaglandin administration have not been 
simultaneously evaluated in previous studies. The consistently 
significant increases in tissue cyclic A}~ content caused by 
both PGE2 and PGF2-alpha in this study, agree with previous 
observations showing a marked stimulation of renal adenylate 
cyclase systems by these agents (187-188). lfuether or not the 
increase in cyclic AMP seen in those studies was coupled with 
corresponding changes in renin release can not be determined, 
since the ttvo parameters ~vere not measured simultaneously. 
Clearly, however, our data indicate that at least at the dose 
used in this study for both prostaglandins, their effects on 
renin release and tissue cyclic A}W content were independent 
of each other. The different effects on these two parameters 
caused by PGE2 and PGF2-alpha administration, contrast with 
data related to the stimulatory effect exerted by catechola-
mines on renin secretion. In these studies (1-4,35,36), 
norepinep:1rine and dopamine significantly stimulated 'oot':: 
renin release and tissue cyclic Al~ content in rat renal 
cortic~l tissu2, sug~estin3 t.:at t~~ re~al ~eceptor ~echanism 
65 
inv·: b;ed L"'l ':hese stLnulato:;:y resoonses utilizes cyclic ~-\:IP as 
a mediator. .?urthermore, the same in"7estigators have shmvn 
that the stimulatory effect of these catecholamines on both 
?arameters, was effectively blocked by t~e beta-adrenoreceptor 
antagonist, ;;)ropranolol, suggesting that the type of receptor 
mechanism mediating these responses is of the beta- type. 
Thus, the marked stimulatory effect of PGE2 and PGF2-alpha on 
tissue cyclic AMP content seen in the present study, may re-
flect a selective, rather than generalized, stimulation of 
renal-adenylate cyclase complexes different from those located 
on the membrane of the JG cells. The observation that propran-
olol administration did not alter the stimulatory effect 
caused by both prostaglandins on tissue cyclic Ai~ content, 
is consistent with this view. 
A number of studies (1,35,36,115,117,212) have also 
shown that renal alpha-adrenergic receptor stimulation marked-
ly depresses renin release and tissue cyclic &•W content, and 
that this inhibitory effect on both parameters is effectively 
converted to stimulation by administration of alpha-adreno-
receptor blocking agents. The present results indicate that 
alpha-adrenergic receptors do not participate in the action 
of PGE2 or PGF2-alpha on either renin release or tissue cyclic 
A~~ content, since alpha adrenoreceptor blockade by p~entolamine 
66 
did not alter the changes seen in both parameters in response 
to administration of either prostaglandin. Thus, it appears 
that neither beta-adrenergic nor alpha-adrenergic receptor 
mechanisms, mediate the stimulatory effect of PGE2 and PGF2 
on the renal cyclic AMP content seen in this study. Also, 
it is clear that at the dose used in this investigation, 
neither prostaglandin was capable of significantly altering 
resting renin release. However, before a definite conclu-
sion regarding the possibility that prostaglandins may in-
fluence renin release can be reached, additional doses of 
these agents must be examine, and alternative prostaglandins 
such as prostacyclin (PGI 2) must be evaluated alone and in 
conjunction ~vith blocking agents. Furthermore, immunohisto-
c:.lemical studies designed to isolate e1e actual site of PG-
stimulated cyclic N,~ content would be of great value in this 
regard. 
In vitro studies utilizing renal cortical tissue of rab-
bits (13,14) have shown that indomethacin, a knmvn prostaglan-
din synthetase inhibitor, significantly suppresses resting 
renin release, an observation which suggests that engcdenous 
renal prostaglandins participate in the minute-to-minute regu-
lation of renin secretion in this species. Similarly, ~omero 
67 
et al. (25) have demonstrated in live dogs that indomethacin 
is a potent inhibitor of resting renin release. Using the 
same concentration of indomethacin, (10-4M), as these \vorkers, 
ive observed a mean decrease in resting renin release after 60 
min of incubation, although this decrease was not statistical-
ly significant. Thus, the present in vitro data do not cur-
rently support t~e concept that resting renin release is under 
partial modulation by intrarenal prostaglandins. Alternative-
ly, our results in the rat may be indicative of species dif-
ferences or of differences in dietary sodium intake, since 
previous studies employed animals maintained on commercial, 
sodium replate diets. The inability of indomethacin to in-
fluence resting renin release in this study, ~vas also apparent 
in regard to the cyclic A~W content of the renal cortical tis-
sue. This observation further supports our view that in vitro 
renin secretion in t~e rat is not regulated to any significant 
extent by endogenous renal prostaglandins, since their activ-
ity should have been reflected in an increased adenylate cy-
clase stiwulation mimicking that observed in this study upon 
administration of exogenous PGE2 and PGF2-alpha. It is clear 
that further studies, designed to determine \vhether or nor the 
marked stimulatory effect exerted by these prostaglandins on 
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renal adenylate cyclase complexes can be altered by simultan-
eous indomethacin administration, are required before these 
questions can be effectively answered. 
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